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Pyrethroid insecticides are used to control diseases spread by
arthropods. We have developed a suite of pyrethroid mimetic
activity-based probes (PyABPs) to selectively label and identify
P450s associated with pyrethroid metabolism. The probes were
screened against pyrethroid-metabolizing and nonmetabolizing
mosquito P450s, as well as rodent microsomes, to measure labeling
speciﬁcity, plus cytochrome P450 oxidoreductase and b5 knockout
mouse livers to validate P450 activation and establish the role
for b5 in probe activation. Using PyABPs, we were able to proﬁle
active enzymes in rat liver microsomes and identify pyrethroid-
metabolizing enzymes in the target tissue. These included P450s
as well as related detoxiﬁcation enzymes, notably UDP-glucurono-
syltransferases, suggesting a network of associated pyrethroid-
metabolizing enzymes, or “pyrethrome.” Considering the central
role P450s play in metabolizing insecticides, we anticipate that
PyABPs will aid in the identiﬁcation and proﬁling of P450s associ-
ated with insecticide pharmacology in a wide range of species,
improving understanding of P450–insecticide interactions and aid-
ing the development of unique tools for disease control.
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Pyrethroids are synthetic analogs of pyrethrins, botanical chem-icals derived from chrysanthemum ﬂowers (1). They are highly
potent insecticides with low mammalian toxicity that are used
worldwide in ∼3,500 registered products in agricultural, medic-
inal, veterinary, and public health sectors. Importantly, they are
the only class of insecticide recommended for insecticide-treated
nets for malaria control. More than 254 million insecticide-
treated nets were distributed across Africa between 2008–2010
(2). Similar to antibiotics, pyrethroids are critical for controlling
a diverse spectrum of diseases. Unfortunately, similar to anti-
biotics, such intense exposure affects health and drives the rapid
evolution of insecticide resistance (3).
Pyrethroids are structurally highly diverse (4) but share a
common architecture comprising a cyclopropane acid group
coupled to an alcohol moiety, as exempliﬁed by deltamethrin
(Fig. 1A). Traditionally, they are divided into two classes (type 1
and type 2), depending on the absence (type 1) or presence (type
2) of an α-cyano group (Fig. 1B). Pyrethroids work by blocking
the voltage-gated sodium channels, causing paralysis in arthro-
pods, and resulting in death (3). Resistance is commonly asso-
ciated with target site modiﬁcation or metabolic resistance, in
which increased rates of biotransformation, generally by P450s,
esterases, and GSTs, reduce toxic potency (3).
Although the toxicity and metabolism of pyrethroids in mam-
mals and insects have been extensively characterized (1), the
role of speciﬁc enzymes and pathways involved in pyrethroid
clearance is unclear. In insects, P450s are key enzymes involved
with metabolic degradation, with constitutive overexpression of
speciﬁc P450s leading to pyrethroid resistance (5, 6). Similarly, in
mammals, the toxic potency of pyrethroids is inversely related to
their rates of metabolic elimination (7), with both P450 oxidation
and carboxyl esterase-mediated hydrolysis playing major roles.
Humans have 57 P450 genes, rodents ∼80 P450 genes, and
insects up to ∼200 P450 genes (8). Where genome information
exists, genetic and microarray-based studies of pyrethroid-
resistant versus susceptible populations have been used to identify
P450s potentially capable of pyrethroid metabolism (3, 5).
However, relatively few P450s have been functionally validated
through recombinant P450 expression. Thus, probes able to
identify pyrethroid-metabolizing enzymes directly would aid our
understanding of the fundamental processes of insecticide–or-
ganism interactions, expanding our understanding of the risks of
pyrethroid exposure to mammals and the enzymatic mechanisms
of metabolism and resistance used by insects.
Activity-based protein proﬁling (ABPP) has been described
for the functional proﬁling of P450s (9, 10). The activity-based
probes (ABPs) work in a mechanism-dependent manner to co-
valently label P450s, whereby the labeling events are detectable
by adding a ﬂuorescent reporter group via copper-catalyzed azide-
alkyne cycloaddition (“click chemistry”) onto the probe−P450
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adducts (9, 10). Furthermore, afﬁnity tags can also be in-
corporated to pull down and identify probe–P450 adducts. The
major advantage of ABPPs is their ability to directly assess en-
zyme activity. In this article, we have designed and synthesized
a group of seven pyrethroid mimetic ABPs (PyABPs) on the
basis of the deltamethrin scaffold (Fig. 1B) for the targeted
identiﬁcation of pyrethroid-metabolizing P450s in highly di-
vergent organisms. We have investigated their reactivity proﬁles
against pyrethroid metabolizing and nonmetabolizing recombi-
nant mosquito P450s and mouse and rat liver microsomes. We
show that PyABPs can be used to reveal pyrethroid structure–
activity relationships, and they also have been used to identify
pyrethroid-reactive P450s and related detoxiﬁcation enzymes in
rat liver microsomes, demonstrating their potential for directly
assessing pyrethroid-metabolizing enzyme activity.
Results and Discussion
Design and Synthesis of PyABPs. To function, P450-ABPs must
contain a reactive alkyne warhead for P450 inactivation and
covalent attachment, as well as an acetylene moiety for click-
chemistry-mediated addition of reporter groups or afﬁnity tags
(Fig. 1B). Thus, a suite of seven PyABPs were synthesized,
varying in the positioning of warhead and click-handles, to in-
vestigate structure–activity relationships and optimize probe re-
activity (Fig. 1A; SI Appendix). The probes were designated as
P2, P3R, P4S, P5R, P6S, P7RS, and P8RS.
All PyABPs apart from P2 were synthesized using a delta-
methrin scaffold. P2 was based on a 2-ethynylnaphthalene
(Probe 1) scaffold, a P450 ABPP with a broad spectrum of ac-
tivity (9). The reactive alkyne groups (warheads) were located on
the phenoxybenzyl alcohol group in the 2′ or 4′ positions to pro-
mote catalysis and mechanism-based inactivation (Fig. 1B), the
predominant sites of P450 oxidation of deltamethrin (11, 12). The
click-handle for ﬂuorescent reporter and/or afﬁnity puriﬁcation tag
attachment was placed terminally, replacing the bromide atoms
on the cyclopropane group to produce type 2 pyrethroids P3R,
P4S, P5R, and P6S, or in the middle, replacing the α-cyano group
on the central alpha carbon to produce type 1 pyrethroids P7RS
and P8RS.
Because the speciﬁcity and rate of metabolic detoxiﬁcation are
dependent on the isomeric state and presence of the α-cyano
substituent, as well as the composition and ﬂexibility of the
phenoxybenzyl group (4), the suite of probes was designed to
allow us to address the positioning effects of the warhead and
click-handles, as well as isomer effects and structural ﬂexibility
(Fig. 1B). As a consequence, type 1 (noncyano) PyABPs P7RS
and P8RS were paired isomer mixtures (R/S; 1:1), differing only
in the positioning of the warhead (4′ and 2′, respectively). Type 2
PyABPs P3R and P4S were pure R and S isomers with a 4′
warhead, whereas P5R and P6S were, respectively, R and S
isomers containing a 2′ warhead. Finally, P2 allowed us to ex-
amine the effect of a rigid planar biphenyl group in place of a
ﬂexible aromatic group on PyABP activity.
Labeling Pyrethroid-Metabolizing P450s and Interrogating Structure–
Activity Relationships. To test their capacity to label P450s, the
PyABPs were screened against two recombinant mosquito
P450s, cytochrome P450 6M2 (CYP6M2) and cytochrome P450
6Z2 (CYP6Z2). These P450s are strongly associated with pyre-
throid resistance in the malaria-transmitting species Anopheles
gambiae, but with contrasting abilities to metabolize deltameth-
rin (11, 13, 14); deltamethrin is metabolized by CYP6M2 but not
CYP6Z2 (15). Probes were added to Escherichia coli mem-
branes coexpressing recombinant P450 and its obligate redox
partner An. gambiae NADPH cytochrome P450 oxidoreductase
(CPR), in the presence or absence of NADPH, to conﬁrm that
P450 labeling occurred in an activity-dependent manner. After
incubation, membranes were treated with an azide-conjugated
Fig. 1. Conversion of deltamethrin into PyABPs. (A) Structure of deltamethrin with constituent acid and alcohol moieties. Primary sites of P450 hydroxylation
are indicated by bold arrows at the 2′ and 4′ positions, and minor routes of hydroxylation are indicated with open arrows (1). (B) Conversion of deltamethrin
to a PyABPP involves the addition of an alkyne warhead and a clickable handle. The structures of the general probe and the PyABPs synthesized are illus-
trated. Alkyne warhead groups were located in the 2′ or 4′ positions, whereas alkyne click handles replaced the cyano group (type 1) or terminal bromides
(type 2). The general P450 probe 2-EN is boxed parallel to its type 1 pyrethroid analog, P2.











Alexa Fluor 488 ﬂuorescent tag under click-chemistry conditions,
resolved by SDS/PAGE, and P450 labeling identiﬁed by in-gel
ﬂuorescence scanning (Fig. 2A). Background (−NADPH) probe
reactivity is commonly observed with ABPs when screening
recombinant P450s (9) and is likely a result of the high P450
content and residual probe binding. Heat maps were therefore
generated by subtraction of −NADPH signals to provide a more
quantitative assessment of probe activity (Fig. 2B).
As expected, the probe-labeling proﬁles of the two P450s were
quite different (Fig. 2), broadly reﬂecting their known capacities
for pyrethroid metabolism (15–17). CYP6M2 reacted strongly
with both P7RS and P8RS but displayed weak activity with the
remaining pyrethroid probes and no activity with P1. In contrast,
CYP6Z2 showed strong reactivity with P1 but weak or no activity
against the PyABPs, apart from P8RS. This provided insight into
their structure–activity relationships. For example, both the
dibromo-vinyl-containing probes P7RS and P8RS were highly
reactive with CYP6M2, despite different warhead positions (2′
and 4′, respectively), in contrast to the less-reactive type 2 probes
with the terminal click-handle replacement (Fig. 2). This sug-
gests an inﬂuential role for the dibromo-vinyl group in PyABP
docking and metabolism. In contrast, loss of the α-cyano group
appeared to have minimal effect on metabolism, which is sup-
ported by the fact that the noncyano pyrethroid permethrin and
the cyano pyrethroid deltamethrin have similar rates of metab-
olism by CYP6M2 (11) Overall, these results suggest that
placement of the acetylene handle at the Cα position provides
the best probe mimetic of deltamethrin.
Metabolism by CYP6M2 was unaffected by the 2′ or 4′ posi-
tioning of the acetylene groups. This is likely a result of the
ﬂexibility of the biphenyl group allowing productive heme–ligand
poses in both warhead positions. Intriguingly, although consid-
ered a nonmetabolizer, CYP6Z2 was highly reactive with P8RS,
indicating that pyrethroid metabolism is possible but structurally
constrained to the 2′ position of the phenoxybenzyl region. This
ﬁts the highly selective substrate proﬁle of this P450, which can
accommodate smaller molecules such as phenoxybenzyl pyre-
throid metabolites 3-phenoxybenzyl alcohol and 3-phenox-
ybenzaldehyde carbaryl and resveratrol, but not larger molecules
such as dichlorodiphenyltrichloroethane and alpha cypermethrin
(16). With respect to isomer effects, in general, the S form of an
α-cyano pyrethroid isomer is more toxic than the R isomer (1).
The effect of the cis versus trans pairings P3R versus P4S and
P5R versus P6S on probe reactivities was inconclusive, as the
probe reactivities were weak.
Probing Redox Partner Interactions in Mouse Liver Microsomes. To
examine the ability of PyABPs to label P450s in a complex
proteome, P7RS, along with P1, P2, P3R, and P8RS, were tested
against mouse liver microsomes in the presence or absence of
NADPH (Fig. 3A). Fluorescent signals in the 50–60-kDa region
were observed in the presence of NADPH, consistent with P450
labeling (9). P7RS produced the strongest signal, along with
P1. P8RS also produced a strong signal, although the sample
had signiﬁcantly less signal difference between −NADPH and
+NADPH; minor labeling occurred in most lanes, either as a
result of residual NADPH in the microsomes or, more likely, as
a reﬂection of high-afﬁnity probe binding. P7RS and P8RS were
also incubated with mouse membranes lacking CPR (18) or cy-
tochrome b5 (b5) (19, 20) to gain insight into the role of P450
redox partners in PyABP metabolism (Fig. 3B). Being the obli-
gate redox partner for P450s, probes were not expected to be
active in CPR knockout mice. The role of b5, in contrast, is un-
clear (11). Previous analysis on individual human P450s has
shown that b5 can stimulate, inhibit, or have no effect on P450-
mediated reactions, depending on the experimental conditions
and substrates analyzed (21, 22), and that it can alter the types of
metabolites produced from a single substrate (23). However,
these data are confounded by the fact that much of the literature
is based on in vitro assays of isolated components. Given that the
activity of many recombinant mosquito P450s that metabolize
pyrethroids are augmented by b5 (11, 16), we were keen to in-
vestigate the inﬂuence of b5 on pyrethroid metabolism in a more
natural context. As expected, labeling was greatly reduced in the
CPR knockout microsomes compared with the normal mouse
liver (Fig. 3B), consistent with a lack of CPR activity (Fig. 3C).
However, both P7RS and P8RS labeled proteins in the 50–60-
kDa size range in b5 knockout mice (CPR/-b5; Fig. 3B), but with
much weaker signal strength. These differences indicate that the
effects of b5 are substrate-dependent. In conclusion, these results
demonstrate that b5 can modulate pyrethroid metabolism in the
liver microsome, providing unique insight into pyrethroid–P450–
b5 interactions.
Fig. 2. PyABP proﬁling with pyrethroid-metabolizing (CYP6M2) and non-
metabolizing (CYP6Z2) mosquito P450s. (A) Fluorescent gel; 50–60-kDa re-
gion of SDS/PAGE separation of E. coli membranes expressing recombinant
P450. (B) Heat maps, with probe structures below, illustrating probe-labeling
proﬁles corresponding to the ﬂuorescent gel lanes; heat signals were nor-
malized by subtraction of −NADPH from +NADPH signals. Fluorescence in-
tensity values are given in arbitrary units.
Fig. 3. Probe labeling of mouse and mosquito microsomes. (A) Treatment
of mouse liver microsomal proteome with P1 and a selection of PyABPs. (B)
Labeling of mouse liver microsomal proteomes from normal (CPR/b5), CPR
knockout (−CPR/b5), and b5 knockout (CPR/-b5) animals with P7RS and P8RS.
(C) CPR activity in mouse liver microsomes.
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Identiﬁcation of the P7RS Interactome (Pyrethrome) in Rat Liver. To
investigate the ability of PyABPs to directly identify pyrethroid-
metabolizing enzymes in native tissue, P7RS labeling of rodent
liver microsomes was performed. Because of the widespread use
of this subcellular fraction for drug metabolism studies, P450
enzymes therein are well-characterized (7). P7RS produced a
strong NADPH-dependent ﬂuorescent signal in the 50–60-kDa
region after labeling and afﬁnity puriﬁcation with a multimodal
reporter, rhodamine–biotin azide (9) (Fig. 4A). After SDS/PAGE
separation, the strongly labeled banding region, between 50 and
60 kDa, was excised and subjected to in-gel trypsin digestion, and
the resulting peptides were analyzed by liquid chromatography
tandem mass spectrometry (LC-MS/MS). Proteins were identiﬁed
using the Mascot search algorithm and semiquantiﬁed by the ex-
ponentially modiﬁed protein abundance index (emPAI), based
on protein coverage by the peptide matches in a database search,
allowing approximate, label-free, relative quantitation of
proteins in a mixture (24). Enzymes that catalyze the bio-
transformation of drugs and xenobiotics are generally classiﬁed
into two main groups: phase 1 oxidative enzymes such as P450s
and phase 2 conjugative enzymes such as UDP-glucuronosyl-
transferases (UGTs) and glutathione S transferases. As expec-
ted, most of the enzymes isolated were P450s (84%, emPAI)
(Fig. 4B; SI Appendix, Table S1), of which CYP2C11 and
CYP2C6 were the two most abundant targets [46% and 19%
(emPAI), respectively; SI Appendix, Table S1]. Importantly, both
CYP2C11 and CYP2C6 exhibit high rates of deltamethrin me-
tabolism (KM, 32 μM, and Vmax, 206 min
−1; and KM, 22 μM, and
Vmax, 150 min
−1, respectively) (7), demonstrating the probes’
ability to target deltamethrin metabolizers. Results were also
consistent with known high levels of expression of CYP2C11 and
CYP2C6 in rat livers (7) and with conﬁrmation of a major role
for these P450s in the oxidative metabolism of deltamethrin in
rats. Two of the other most abundant P450s pulled-down by P7RS,
CYP2C13 and CYP2D1 (SI Appendix, Table S1), are known to
metabolize pyrethroids (7, 12, 25), reiterating the probe’s ability
to identify pyrethroid-metabolizing P450s. CYP3A2, a highly
expressed P450 in rat liver that metabolizes pyrethroids (7), was
notably present in the low-abundance fraction (1%). This is con-
sistent with a lower rate of deltamethrin metabolism and a minor
role in deltamethrin metabolism in rat liver (7) and suggests that
biologically relevant probe interactions extend to the low-abun-
dance enzyme fraction.
For further validation, experiments were repeated using a
slightly different approach. Here, P7RS-bound proteins were
afﬁnity-puriﬁed on streptavidin beads, using a biotin-azide re-
porter, followed by on-bead trypsin digestion instead of gel-band
excision. LC/MS of resultant peptides identiﬁed a similar set of
enzymes, with CYP2C11 as the top hit followed by CYP2D10
and CYP2D1 (SI Appendix, Table S2). CYP2D1 metabolizes
α-cypermethrin, λ-cyhalothrin, and β-cyﬂuthrin (12), which are
pyrethroids that are structurally similar to deltamethrin. It also
shares high-amino-acid identity with CYP2D10 (96%) and the
other members of the CYP2D family that were pulled-down (SI
Appendix, Tables S1 and S2). Percentage identities were as fol-
lows: CYP2D3 (79% identity), CYP2D26 (73%), CYP2D4 (72%),
and CYP2D18 (72%), suggesting a common ability to metabolize
pyrethroids. Although similar sets of enzymes were identiﬁed
by in-gel and on-bead trypsin digestion, there were notable
differences in their rank order. This likely reﬂects differences
in sensitivities of the two approaches, as well as differences in
microsome preparations.
It was also evident that several enzymes other than P450s also
reacted with P7RS. Interestingly, all were drug-metabolizing
enzymes, suggesting functional rather than nonspeciﬁc probe
interactions, consistent with the fact that ABPs are reported to
capture functional pathways (26). This may occur through pro-
tein–protein interactions or by transient diffusion of a reactive
probe intermediate out of the active site of a P450, followed by
reaction with a protein in close proximity to the P450 (9, 27).
Overall, P7RS interactions with rat liver microsomes suggest
a network of drug-metabolizing enzymes associated with pyre-
throid metabolism, or “pyrethrome.” There is accruing evidence
that orchestrated interactions between P450s and UGTs, which
lie opposite P450s on the luminal side of the endoplasmic re-
ticulum, may facilitate the channeling and excretion of toxic and
reactive intermediate metabolites (28–30). This is supported
here by the interactions of UDP-glucuronosyltransferases 2B2,
2B3, 2B4 and 2B5 (UDP-g 2Bs 2–5) with P7RS (Fig. 4 and SI
Appendix, Tables S1 and S2). Indeed, glucuronide conjugation of
permethrin ester hydrolysis products has been demonstrated in
rats (31), and thus, such compounds could form protein–pyrethroid
Fig. 4. Proteins identiﬁed in a rat liver microsomal proteome by P7RS and in-gel LC-MS/MS. (A) P7RS targets were detected after labeling by click chemistry
(preafﬁnity lanes) and afﬁnity puriﬁcation (postafﬁnity lanes) with a rhodamine–biotin azide tag by SDS/PAGE and in-gel ﬂuorescence. The enriched afﬁnity
puriﬁed P450 band (∼50–60 kDa) visible by Coomassie staining was excised for LC-MS/MS proteomic analysis. (B) Percentage constitution of detoxiﬁcation
enzymes labeled by P7RS. (C) Percentage constitution of individual P450s identiﬁed. Percentage constitutions were calculated on the basis of emPAI for each
protein relative to the total emPAI, as indicated in Methods.











conjugates on transacylation or via Amadori product formation
(31). Flavin-containing monooxygenase 3 (2%, emPAI), which
catalyzes the NADPH-dependent oxygenation of various nitrogen-,
sulfur-, and phosphorus-containing xenobiotics, and ALDH3a2,
which is responsible for the oxidation of aldehyde to carboxylic
acids, were also present (Fig. 3). Whether close contact inter-
actions occur with P450s and/or UGTs in connection with a co-
ordinated pyrethrome-mediated metabolism of pyrethroids has
yet to be established.
Conclusions
Here, we have synthesized and tested a unique panel of ABPs
and PyABPs directed toward pyrethroid-metabolizing P450s.
Screening of the probes against recombinant mosquito P450s
identiﬁed optimal probes for P450s that metabolized pyrethroid
substrates. One such probe, P7RS, was taken forward to establish
its capabilities as a deltamethrin mimic probe. We have dem-
onstrated that P7RS was capable of detecting deltamethrin-
metabolizing P450s in a complex rat proteome, as well as UGT
and other enzymes associated with xenobiotic metabolism. These
may simply reﬂect individual, but unrelated, probe interactions.
However, our favored interpretation is that the probe has cap-
tured a pyrethrome, an associated network of enzymes involved
in pyrethroid metabolism. Regardless, the power of the PyABP
to directly assess pyrethroid metabolizing activity is signiﬁcant.
Considering the central role that P450s play in insecticide me-
tabolism, we anticipate that PyABPs will prove of value for
assessing P450–pyrethroid interactions in a wide range of species
and biological systems, and in tropical diseases in particular. For
instance, in 2012, largely in response to escalating pyrethroid
resistance, the World Health Organization launched an inter-
national call to action with its Global Plan for Insecticide Re-
sistance Management for Malaria Vectors (32). The probes
described here could be used to proﬁle P450s associated with
pyrethroid resistance in a wide spread of mosquito vectors, to
characterize mechanisms of resistance and identify potential
resistance markers. Similarly, they would be of value for proﬁling
metabolic resistance in veterinary and agricultural pests, where
pyrethroids are used extensively. Finally, ABPs are versatile in
probing drug interactions in vivo (9, 10). Given that the pharma-
cology of insecticide metabolism is poorly understood in relation
to drug metabolism, PyABPs may be used in the future to facilitate
the functional characterization of insecticide activity in vivo.
Methods
Chemicals and Reagents. β-Nicotinamide adenine dinucleotide phosphate,
reduced form, tetrasodium salt (NADPH) was obtained from Melford. Lu-
minescent P450 activity assays were performed in white 96-well plates
(Thermo Fisher Scientiﬁc), using the commercially available P450-Glo’s sub-
strate Luciferin-PPXE (Promega). DMSO solvents were reagent-grade (Sigma
Aldrich). The click-chemistry ligand, Tris [(1-benzyl-1H-1, 2, 3-triazol-4-yl)
methyl] amine, was purchased from Sigma-Aldrich Chemical Co. Alexa Fluor
488 azide and biotin azide were purchased from Invitrogen. The chemical
synthesis of the probes (PyABPs) is described in SI Appendix.
Preparation of Membranes Expressing P450s. E. coli membranes coexpressing
CYP6M2 or CYP6Z2 with CPR were prepared as previously described (11, 15).
Rat liver microsomes were prepared from male Wistar rats kindly provided
by Alison Shone (Molecular Biochemical Parasitology group, Liverpool School
of Tropical Medicine, Liverpool, United Kingdom).
Male mouse liver microsomes samples, kindly provided by Roland Wolf
(Biomedical Research Institute, University of Dundee, United Kingdom), were
prepared from transgenic animals that have conditional deletions of liver CPR
or b5 along with normal mouse controls, as described (20, 33).
Probe Labeling of Pyrethroid-Metabolizing P450s. Recombinant P450s CYP6M2
and CYP6Z2 were normalized to 0.2 μM in Ca2+ and Mg2+ free Dulbecco’s
Phosphate Buffer Saline (D-PBS; Invitrogen) at pH 7.4 and treated with
probes at 20 μM in the presence and absence of 1 mM NADPH. All probes
were prepared as 20-mM stock solutions in DMSO. Samples were incubated
at 37 °C for 1 h. Thereafter, 44 μL of sample was transferred to an Eppendorf
tube for addition of 0.5 μL Alexa Fluor 488 azide reporter (5 mM stock so-
lution in DMSO). After addition of the reporter, the click chemistry reaction
proceeded with conditions optimized by Speers and Cravatt (34) Brieﬂy,
samples were treated with 1 μL Alexa Fluor 488 azide reporter (2.5 mM stock
in DMSO), followed by 1 μL freshly prepared Tris(2-carboxyethyl)phosphine
hydrochloride (50 mM stock in water) and 3.3 μL ligand (1.7 mM stock in
DMSO:t-butanol 1:4), giving a t-butanol concentration of 5% (vol/vol).
Samples were gently vortexed, and 1 μL CuSO4 (50 mM stock in water) was
added. Each sample was gently vortexed and allowed to react at room
temperature for 1 h in the dark, with regular vortexing every 15 min.
NuPAGE Novex 4–12% Bis-Tris Gels (Invitrogen) were used for protein sep-
aration, whereby 2× SDS/PAGE loading buffer (reducing) was added to each
reaction, the samples were heated at 90 °C for 8 min, and then 30 μL per well
were loaded onto gels. Gels were destained (5:4:1 water/methanol/acetic
acid) overnight in the dark, and ﬂuorescence intensities were measured
using an Ettan DIGE Laser imager (GE Healthcare) with a CY2 ﬁlter. Equal
protein loading was conﬁrmed by post scanstaining with Gel code Blue
Coomassie stain (Pierce).
Probe Labeling of Rodent Microsomes. Rat liver microsomes were normalized
to 2 mg/mL protein and treated with 20 μM PyABPs in the presence and
absence of 1 mM NADPH. For mouse liver microsomes, the P450 contents
were adjusted to 0.2 μM and treated with 20 μM PyABPs in the presence and
absence of 1 mM NADPH. Samples were incubated at 37 °C for 1 h and then
labeled proteins were identiﬁed by gel ﬂuorescence scanning, after
appending AlexaFluor488-azide at 25 μM to labeled proteome via click-
chemistry, as described earlier.
Identiﬁcation of P7RS Metabolizing Enzymes in Rat Liver Microsomes. One
microliter rat liver microsomes (2 mg/mL protein in PBS) was treated with 2.0
μL probe P7RS (10 mM stock solution in DMSO) in the presence or absence of
1 mM NADPH. The samples were incubated at 37 °C for 45 min and then
treated with a multimodal biotin–rhodamine azide reporter group for in-gel
detection or a biotin–azide reporter for on-bead trypsin digestin (both 4.0 μL
of a 5 mM stock solution in DMSO), followed by vortexing. The click reaction
was preceded by addition of click-chemistry reagents, as previously de-
scribed, and left at room temperature in the dark for 1 h. Rhodamine–biotin
azide tag-labeled proteins were enriched with streptavidin agarose beads, as
previously mentioned (9). Brieﬂy, samples were centrifuged (5,900 × g,
4 min, 4 °C) to pellet the protein. The supernatant was discarded, cold
methanol (0.40 mL) was added to the pellets, and the proteins were resus-
pended by sonication (3–5 s) and then rotated (10 min, 4 °C). The centrifu-
gation step was repeated, the supernatant was discarded, methanol (0.40
mL) was added to the pellets, and the proteins were resuspended by soni-
cation (3–5 s) and then rotated (10 min, 4 °C) once again. The samples were
pelleted by centrifugation once more, and the supernatant discarded. PBS
(1.0 mL) containing SDS (1.2%, vol/vol) was added to the pellets and sub-
sequently resuspended by sonication (3–5 s). The samples were heated at
90 °C for 8 min and then cooled to room temperature. Proteins were then
enriched by rotating samples (1.5 h) with streptavidin-agarose beads (0.1 mL
suspension solution) in a PBS media diluted to 0.2% SDS. The PBS media was
removed, and the beads were rinsed with 0.2% SDS in PBS (1.5 mL, 3×), urea
(6.0 M, 1.5 mL, 3×), and PBS buffer (1.5 mL, 3×).
For in-gel detection, SDS/PAGE loading buffer (2×, reducing, 50 μL) was
added to the beads and heated at 90 °C for 8 min. The samples (35 μL) were
loaded onto SDS/PAGE gels and separated. Gels were imaged onto Ettan DIGE
Laser imager (GE Healthcare) at CY3 ﬁlter to determine the labeling in pres-
ence and absence of NADPH. After imaging, the gel Coomassie stained, using
Gel code Blue Coomassie stain (Pierce). The darkly stained bands from 48 to 55
kDa were excised with a razor blade and diced into small cubes. The gel pieces
were washed with water and sent to Dundee University (http://proteomics.
lifesci.dundee.ac.uk/service-rates) for trypsin digestion and LC-MS/MS analysis.
For on-bead trypsin digestion, probe-labeled proteins were enriched and
identiﬁed after the click reaction incubation reaction, using streptavidin
agarose beads, as described previously (35).
Proteins were identiﬁed using the Mascot search algorithm and
semiquantiﬁed by the emPAI (24). This value offers approximate, label-
free, relative quantitation of proteins in a mixture. This is obtained on
the basis of protein coverage by the peptide matches in a database
search. Data were ﬁltered on the ions score, which is calculated using −10·Log
(P), where P is the probability that the observed match is a random event. In-
dividual ions scores >41 indicate identity or extensive homology (P < 0.05).
Protein scores were derived from ion scores on a nonprobabilistic basis for
ranking protein hits.
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